Ebola: Windfall for military-industrial complex
Ebola: Windfall for military-industrial complex
Sun Nov 2, 2014 1:19AM GMT
On October 31, Profectus BioSciences, Inc. announced it has received millions of dollars to develop an Ebola vaccine.
The Pentagon awarded the contract through its Medical Countermeasure Systems-Joint Vaccine Acquisition Program, a program that develops and stockpiles vaccines to be used on soldiers.
“The $9.5 million award has been made with Battelle Memorial Institute through the Chemical, Biological, Radiological, & Nuclear Defense Information Analysis Center,” a PRNewswire released on Friday states.
CBRNIAC is part of the Pentagon’s Defense Technical Information Center. DTIC provides a “suite of services” to defense contractors and academic institutions. It also provides services of the Homeland Security “community.”
“We are continuing to develop a trivalent vaccine that will protect our service members and DoD civilians against the major filovirus threats: Ebola Zaire, Ebola Sudan, and Marburg viruses,” said the manager of the Pentagon’s Medical Countermeasure Systems-Joint Vaccine Acquisition Program. “The DoD is optimistic that its long-term commitment to identifying and supporting safe and effective trivalent filovirus vaccines is coming to fruition and remains supportive to advancing the Profectus BioSciences trivalent Ebola/Marburg vaccine into human clinical trials as rapidly as possible.”
Earlier in the week, the Medical Countermeasure Systems-Joint Vaccine Acquisition Program awarded Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource Center $2 million to work on an Ebola and Marburg vaccine. “Among MCS-JVAP’s requirements is to develop a vaccine to protect soldiers from exposure to filoviruses, which cause several types of hemorrhagic fever,” Global Biodefense reports.
From Military Guinea Pigs to Civilians
The move by the Pentagon represents the militarization of Ebola vaccine effort. “While the primary purpose of the Ebola vaccine would be to protect U.S. soldiers, it is possible that such a vaccine could be used for endemic outbreaks of filovirus infection,” the website notes.
Soldiers will become guinea pigs for a vaccine destined for public application. On October 27, USA Today reported the center at CSU “develops and stockpiles vaccines and countermeasures that can be used to protect soldiers, but the research ultimately will benefit civilians.”
The link between the Pentagon and defense contractors raises serious questions, writes Julie Lévesque. “This link between the U.S. military and pharmaceutical companies in the production of flu vaccines raises serious questions, especially since the H1N1 pandemic has been exposed as a multibillion dollar fraud instigated by Big Pharma and the World Health Organization (WHO),” Lévesque wrote after Medicago, a corporation owned by Mitsubishi Tanabe Pharma Corp. and Philip Morris, began work on an Ebola antibody. In 2012, Medicago partnered with the Pentagon on the development of an influenza vaccine.
On October 1 Infowars.com reported on the Pentagon’s funding of an Ebola vaccine under a $140 million project with Tekmira Pharmaceuticals, a Canadian company.
“It is clear that the US government has been keeping tabs on Ebola for a while now,” writes Dave Mihalovic for Prevent Disease. “It holds the patents on a strain of the Ebola virus known as Bundibugyo (EboBun) that was found in Uganda. It is although not clear whether it is the same strain that has created the current epidemic. The patent, awarded in October 2012 to five scientists led by Jonathan S Towner, is now deposited with the US Centers for Disease Control and Prevention.”
Many Believe Ebola Released to Benefit Big Pharma and Military Industrial Complex
Many Africans believe Ebola was unleashed on West Africa in order to create a pandemic that would require a vaccine.
“Reports narrate stories of the US Department of Defense (DoD) funding Ebola trials on humans, trials which started just weeks before the Ebola outbreak in Guinea and Sierra Leone. The reports continue and state that the DoD gave a contract worth $140 million dollars to Tekmira, a Canadian pharmaceutical company, to conduct Ebola research. This research work involved injecting and infusing healthy humans with the deadly Ebola virus,” writes Dr. Cyril Broderick, a former professor of Plant Pathology at the University of Liberia’s College of Agriculture and Forestry.
Broderick claims Ebola is a genetically modified organism designed by the “American Military-Medical-Industry that conducts biological weapons tests under the guise of administering vaccinations to control diseases” in Africa and other third world countries. Broderick also claims the World Health Organization and other United Nations agencies “have been implicated in selecting and enticing African countries to participate in the testing events” and are “promoting vaccinations.”
M. Durga Prasad of India’s Defense Research & Development Organization recently raised the hackles of the establishment media when he said the Ebola outbreak could be part of a biological warfare program.
As noted by Infowars.com, the Pentagon and the CIA have a long track record of releasing deadly viruses on the public.